Conversion from Cyclosporine to Tacrolimus improves Renal Function and Lipid Profile after Cardiac Transplantation
Miroslaw Garlicki, Pawel Czub, Krzysztof Labus, Marek P Ehrlich, Hanna RdzanekAnn Transplant 2006; 11(1): 24-27 :: ID: 496936
Abstract
Background: Calcineurin inhibitors (CNIs) have become the cornerstone of immunosuppressive regimens following heart transplantation, but their use is associated with nephrotoxicity. The impact on renal function after conversion from cyclosporine (CsA) to tacrolimus (TAC) is reported. Patients and methods: Fifteen patients (men age 42±11 years) after cardiac transplantation (HTX) were switched from CsA to TAC (mean time after HTX 21±6 month). There were 13 male and 2 female patients. Mean cholesterol and LDL level at the time of conversion were 217±65 ml/dl and and 136±51 mg/100ml respectively. Indication for HTX was ischemic cardiomyopathy (CMP) in 8, congenital in 3 and dilatative CMP in the remaining 4 patients. Results: Mean tacrolimus level (μg/dl) at 1, 3, 6 and 12 months were 8.6±3.3, 8.6±1.4, 9.2±2.8 and 9.8±2.5 respectively. There was a statistically significant improvement in creatinine levels at 1, 3, 6 and 12 months after conversion from baseline 1.9±0.7mg/dl to 1.4±0,5 mg/dl, 1.4±0.4 mg/dl, 1.3±0.4 mg/dl and 1.2±0.4 mg/dl, respectively (p< 0.05). Furthermore, TAC decreased cholesterol as well as LDL-levels during this one-year time frame. Conclusion: This study shows that conversion from CsA to tacrolimus after orthotopic heart transplantation improves renal function.
Keywords: Heart Transplantation, Renal Function, lipid profile
In Press
18 Mar 2024 : Original article
Does Antibiotic Use Increase the Risk of Post-Transplantation Diabetes Mellitus? A Retrospective Study of R...Ann Transplant In Press; DOI: 10.12659/AOT.943282
20 Mar 2024 : Original article
Transplant Nephrectomy: A Comparative Study of Timing and Techniques in a Single InstitutionAnn Transplant In Press; DOI: 10.12659/AOT.942252
28 Mar 2024 : Original article
Association Between FEV₁ Decline Rate and Mortality in Long-Term Follow-Up of a 21-Patient Pilot Clinical T...Ann Transplant In Press; DOI: 10.12659/AOT.942823
02 Apr 2024 : Original article
Liver Transplantation from Brain-Dead Donors with Hepatitis B or C in South Korea: A 2014-2020 Korean Organ...Ann Transplant In Press; DOI: 10.12659/AOT.943588
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860